In colorectal cancer research, ABLIM1, as a novel E3 ligase, can specifically bind to IĸBα and promote its ubiquitination and degradation, activating the NF-κB/CCL-20 signaling pathway and significantly promoting the malignant biological behaviors of CRC cells. This evidence concerns the gene NFKB1 and colorectal carcinoma.